The Valley Desk

ArticleThe British journal of dermatologyPublished

Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
The British journal of dermatology
Published
Subject terms
Humans; Neoplasms; Psoriasis; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Antibodies, Monoclonal, Humanized; Adalimumab
PubMed ID
36944555
Added to directory
Source checked

Report a correction or request removal